These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 37935817)
41. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed. Digomann D; Linge A; Dubrovska A Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435 [TBL] [Abstract][Full Text] [Related]
42. Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays. Maalouf M; Alphonse G; Colliaux A; Beuve M; Trajkovic-Bodennec S; Battiston-Montagne P; Testard I; Chapet O; Bajard M; Taucher-Scholz G; Fournier C; Rodriguez-Lafrasse C Int J Radiat Oncol Biol Phys; 2009 May; 74(1):200-9. PubMed ID: 19362238 [TBL] [Abstract][Full Text] [Related]
43. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis. Overgaard J Radiother Oncol; 2011 Jul; 100(1):22-32. PubMed ID: 21511351 [TBL] [Abstract][Full Text] [Related]
44. The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma. Zhou C; Parsons JL Expert Rev Mol Med; 2020 Jul; 22():e3. PubMed ID: 32611474 [TBL] [Abstract][Full Text] [Related]
45. Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma. Freudlsperger C; Horn D; Weißfuß S; Weichert W; Weber KJ; Saure D; Sharma S; Dyckhoff G; Grabe N; Plinkert P; Hoffmann J; Freier K; Hess J Int J Cancer; 2015 Jun; 136(12):2775-85. PubMed ID: 25388642 [TBL] [Abstract][Full Text] [Related]
46. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases. Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539 [TBL] [Abstract][Full Text] [Related]
47. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers. Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240 [TBL] [Abstract][Full Text] [Related]
48. Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years. Blatt S; Voelxen N; Sagheb K; Pabst AM; Walenta S; Schroeder T; Mueller-Klieser W; Ziebart T Clin Oral Investig; 2016 Nov; 20(8):2097-2104. PubMed ID: 26728026 [TBL] [Abstract][Full Text] [Related]
49. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses. You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292 [TBL] [Abstract][Full Text] [Related]
50. Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air. Morse RT; Mell LK Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):783-785. PubMed ID: 38851276 [No Abstract] [Full Text] [Related]
51. Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells Park JJ; Hah YS; Ryu S; Cheon SY; Cho HY; Kim JP; Won SJ; Lee JS; Hwa JS; Seo JH; Chang HW; Kim SY Anticancer Res; 2020 May; 40(5):2627-2635. PubMed ID: 32366407 [TBL] [Abstract][Full Text] [Related]
52. Pulsed low dose-rate irradiation response in isogenic HNSCC cell lines with different radiosensitivity. Todorovic V; Prevc A; Zakelj MN; Savarin M; Bucek S; Groselj B; Strojan P; Cemazar M; Sersa G Radiol Oncol; 2020 Mar; 54(2):168-179. PubMed ID: 32229678 [TBL] [Abstract][Full Text] [Related]
53. Combination antiangiogenic therapy and radiation in head and neck cancers. Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532 [TBL] [Abstract][Full Text] [Related]
54. Telomerase-specific oncolytic adenovirus: antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells. Takahashi H; Hyakusoku H; Horii C; Takahashi M; Nishimura G; Taguchi T; Kondo N; Sakakibara A; Urata Y; Sano D Head Neck; 2014 Mar; 36(3):411-8. PubMed ID: 23728900 [TBL] [Abstract][Full Text] [Related]
55. Association of ALDH1 with Response to Radiotherapy and Its Impact on Survival in Patients with Advanced Stage of Head and Neck Squamous Cell Carcinoma (HNSCC). Dubey P; Kumar N; Gupta R; Mishra A; Bhadauriya S; Kumar V; Bhatt MB Asian Pac J Cancer Prev; 2022 Feb; 23(2):419-427. PubMed ID: 35225452 [TBL] [Abstract][Full Text] [Related]
56. Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Jerhammar F; Ceder R; Garvin S; Grénman R; Grafström RC; Roberg K Cancer Biol Ther; 2010 Dec; 10(12):1244-51. PubMed ID: 20930522 [TBL] [Abstract][Full Text] [Related]
57. Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma. Schoetz U; Klein D; Hess J; Shnayien S; Spoerl S; Orth M; Mutlu S; Hennel R; Sieber A; Ganswindt U; Luka B; Thomsen AR; Unger K; Jendrossek V; Zitzelsberger H; Blüthgen N; Belka C; Unkel S; Klinger B; Lauber K Cell Death Dis; 2021 Dec; 12(12):1162. PubMed ID: 34911941 [TBL] [Abstract][Full Text] [Related]
58. Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens. Meneceur S; Löck S; Gudziol V; Hering S; Bütof R; Rehm M; Baumann M; Krause M; von Neubeck C Radiother Oncol; 2019 Aug; 137():24-31. PubMed ID: 31048234 [TBL] [Abstract][Full Text] [Related]
59. HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity. Tong F; Mao X; Zhang S; Xie H; Yan B; Wang B; Sun J; Wei L Cancer Lett; 2020 May; 478():34-44. PubMed ID: 32120025 [TBL] [Abstract][Full Text] [Related]
60. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]